Начало・Списък с акции・Stryker Corp

Stryker Corp

Отворен

СекторЗдравеопазване

337.76 -0.9

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

334.39

Максимум

341.74

Ключови измерители
By Trading Economics
Приходи	531M 1.3B
Продажби	569M 6.6B
P/E Средно за сектора	35.072 57.002
EPS	3.69
Дивидентна доходност	1.03
Марж на печалбата	19.366
Служители	56,000
EBITDA	266M 1.6B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+12.82% upside

Дивиденти
By Acuity
Дивидентна доходност Средно за сектора	1.03% 2.22%
Следващи печалби	29.10.2026 г.
Следваща дата на дивидент	30.10.2026 г.
Следваща дата на екс-дивидент	29.09.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	3.6B 133B
Предишно отваряне	338.66
Предишно затваряне	337.76

Настроения в новините

By Acuity

61%

39%

296 / 340 Класиране в Healthcare

Stryker Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.08.2026 г., 20:06 ч. UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

12.08.2026 г., 19:16 ч. UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

11.08.2026 г., 23:26 ч. UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

10.08.2026 г., 23:06 ч. UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

7.08.2026 г., 20:06 ч. UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

6.08.2026 г., 20:06 ч. UTC

Macro Event

News

Stryker Corp shares are lower as supply chain disruptions impact sales, despite meeting revenue expectations of $6.59 billion and adjusted EPS of $3.69.

5.08.2026 г., 23:12 ч. UTC

Stryker Corp shares are lower in after-market hours, reflecting unusual trading behavior and a decline in momentum since Wednesday's close. No specific news was identified.

4.08.2026 г., 19:56 ч. UTC

Stryker Corp shares are lower today, reflecting broader market trends amid a significant drop in crude oil prices since Monday's close.

3.08.2026 г., 20:03 ч. UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

31.07.2026 г., 23:16 ч. UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

30.07.2026 г., 23:41 ч. UTC

Social Media

News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

29.07.2026 г., 22:41 ч. UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

28.07.2026 г., 20:51 ч. UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

27.07.2026 г., 19:06 ч. UTC

Social Media

News

Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

24.07.2026 г., 23:36 ч. UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

22.07.2026 г., 20:46 ч. UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

21.07.2026 г., 18:16 ч. UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

20.07.2026 г., 20:41 ч. UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Сравнение с други в отрасъла

Ценова промяна

Stryker Corp Прогноза

Ценова цел

By TipRanks

12.82% нагоре

12-месечна прогноза

Среден 384.82 USD 12.82%

Висок 455 USD

Нисък 340 USD

Според 18 анализатори от Wall Street, предложили 12-месечна ценова цел за Stryker Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

18 ratings

Купи

Задържане

Продай

Според 18 анализатори, дали борсови рейтинги на Stryker Corp през последните 3 месеца.

Настроение

By Acuity

296 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.